Quotient (NASDAQ:QTNT) will announce its earnings results after the market closes on Monday, February 5th. Analysts expect the company to announce earnings of ($0.55) per share for the quarter.
Quotient (NASDAQ:QTNT) last announced its quarterly earnings data on Monday, October 30th. The company reported ($0.58) EPS for the quarter, beating analysts’ consensus estimates of ($0.59) by $0.01. Quotient had a negative return on equity of 13,050.41% and a negative net margin of 404.29%. On average, analysts expect Quotient to post $-2 EPS for the current fiscal year and $-1 EPS for the next fiscal year.
Shares of Quotient (QTNT) opened at $3.27 on Monday. Quotient has a 52-week low of $3.20 and a 52-week high of $7.74. The company has a market capitalization of $148.98, a price-to-earnings ratio of -1.14 and a beta of 1.40. The company has a debt-to-equity ratio of -5.17, a quick ratio of 0.86 and a current ratio of 1.36.
A number of equities research analysts have recently commented on QTNT shares. Zacks Investment Research downgraded Quotient from a “hold” rating to a “sell” rating in a research report on Thursday, November 2nd. BTIG Research reiterated a “buy” rating and set a $12.00 price objective on shares of Quotient in a research report on Wednesday, November 1st. Finally, Jefferies Group cut their price objective on Quotient from $15.00 to $13.00 and set a “buy” rating for the company in a research report on Wednesday, November 1st.
Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. California State Teachers Retirement System purchased a new stake in shares of Quotient in the second quarter valued at $349,000. The Manufacturers Life Insurance Company purchased a new stake in shares of Quotient in the second quarter valued at $177,000. State Street Corp purchased a new stake in shares of Quotient in the second quarter valued at $1,728,000. Finally, Vanguard Group Inc. purchased a new stake in shares of Quotient in the second quarter valued at $523,000. Institutional investors own 47.43% of the company’s stock.
TRADEMARK VIOLATION WARNING: “Quotient (QTNT) Set to Announce Quarterly Earnings on Monday” was originally reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this piece on another domain, it was copied illegally and republished in violation of US and international trademark & copyright laws. The correct version of this piece can be read at https://www.dispatchtribunal.com/2018/01/29/quotient-qtnt-set-to-announce-quarterly-earnings-on-monday.html.
Quotient Limited is a diagnostics company. The Company focuses on blood grouping and donor disease screening, which is referred to as transfusion diagnostics. It is engaged in developing, manufacturing and commercializing conventional reagent products used for blood grouping within the global transfusion diagnostics market.
Receive News & Ratings for Quotient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quotient and related companies with MarketBeat.com's FREE daily email newsletter.